You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Cytomegalovirus Encephalitis in an Allogeneic Hematopoietic Cell Transplant Recipient: A Case Report and Review of Literature

Yacoub, Abraham MD*; Besaw, Laura ARNP*; Pasikhova, Yanina PharmD; Kharfan-Dabaja, Mohamed A. MD; Sandin, Ramon L. MD, MS, FCAP§; Greene, John MD, FACP*

Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0000000000000156
Case Reports
Abstract

Abstract: Cytomegalovirus (CMV) commonly reactivates in seropositive recipients after allogeneic hematopoietic cell transplant but rarely causes infection. Since the implementation of preemptive approaches, infection by CMV has become a rare occurrence. We describe the successful treatment of a case of late ganciclovir-resistant CMV encephalitis occurring 2 ½ years after an HLA-mismatched allogeneic hematopoietic stem cell transplant.

Author Information

From the *H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine; and †Infectious Diseases, ‡Department of Blood and Marrow Transplantation, and §Clinical Microbiology and Virology Laboratories, Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, FL.

Correspondence to: John Greene, MD, FACP, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, 12902 Magnolia Drive, Tampa, FL. E-mail: john.greene@moffitt.org.

The authors have no funding or conflicts of interest to disclose.

© 2014 by Lippincott Williams & Wilkins.